As women navigate the hormonal shifts of perimenopause and menopause, many explore natural options like vitex (chasteberry) to support their well-being. A common and important question that arises concerns the safety of supplements for vital organs, particularly the liver and kidneys.
This article provides an evidence-based overview of what current research suggests regarding the effects of vitex on the liver and kidneys, specifically highlighting findings from scientific studies. It’s important to remember that while some research exists, the evidence is still limited, and more human studies are needed to draw definitive conclusions.
Understanding Vitex and Organ Health: An Overview
Vitex agnus-castus, commonly known as chasteberry, has a long history of traditional use. As with any botanical supplement, understanding its potential interactions and effects on the body’s major organs, such as the liver and kidneys, is crucial. These organs play essential roles in detoxification and overall health.
When considering how vitex affects the liver and kidneys, it’s important to look at both potential protective effects and any reported adverse reactions. The available research, while not extensive in human populations specifically on this topic, offers some insights into how different species of Vitex might interact with these organs. The current evidence on how vitex affects these organs is limited, and many studies are conducted in animal models or focus on specific extracts rather than the whole herb commonly used by women.
What the Human Safety Record Shows for Vitex Agnus-Castus
The studies described in the next two sections all involve other Vitex species. For Vitex agnus-castus itself, the most directly relevant human evidence is a systematic review of adverse events, which searched six electronic databases together with the spontaneous reporting schemes of the World Health Organization and national drug safety bodies, and additionally contacted twelve manufacturers and five herbalist organisations. It found the adverse events following vitex treatment to be mild and reversible. The events it identified as most frequent were nausea, headache, gastrointestinal disturbance, menstrual disorders, acne, itching and a red rash; no liver or kidney event appears among them. The review concluded that the available data indicate vitex is a safe herbal medicine, while noting that further rigorous studies are still needed[1]. A later systematic review of twelve randomised controlled trials likewise reported that adverse events with vitex extracts were mild and generally infrequent[2].
Two limits on that reassurance are worth stating plainly. First, no clinical trial of vitex has measured liver or kidney function as an endpoint, so the absence of organ-related adverse events reflects what happened to be reported rather than what was actively looked for. Second, those trials were designed to test whether vitex relieves premenstrual and cycle-related symptoms over a small number of cycles, not to detect uncommon or slow-developing effects, so they cannot speak to years of continuous use. If you already have liver or kidney disease, or take medication that depends on those organs, that is a conversation for your clinician rather than a question the published evidence can settle.
Vitex and Liver Function: What the Research Suggests
Several studies have explored the potential effects of various Vitex species on liver health, primarily in animal models. Some research suggests that certain Vitex extracts may exhibit hepatoprotective qualities under specific experimental conditions. For example, a standardized extract of Vitex doniana Sweet was observed to help stall protein oxidation, lipid peroxidation, and DNA fragmentation in an acetaminophen-induced hepatotoxicity model [3].
Another study indicated that an extract from Vitex negundo leaves showed hepatoprotective activity against liver injury induced by anti-tubercular drugs [4]. Additionally, research on Vitex leucoxylon L. has also explored its potential hepatoprotective activity [5]. These findings suggest potential protective mechanisms in specific contexts but are not directly transferable to general human use or specific to Vitex agnus-castus in healthy individuals.
It’s important to emphasize that these studies often use specific extracts or isolated compounds from different Vitex species and are conducted in animal models of induced liver damage. This means that while they offer interesting avenues for further research, they do not provide direct evidence of Vitex agnus-castus’s impact on liver health in healthy perimenopausal women or its liver and kidney safety profile under normal circumstances. The evidence regarding vitex and liver or kidney safety in humans is still limited.
Vitex and Kidney Health: Exploring the Evidence
Similar to liver research, studies investigating Vitex and kidney health have predominantly been conducted in animal models. One study examined the effect of an ethanolic extract of Vitex negundo on thioacetamide-induced nephrotoxicity (kidney damage) in rats [6]. The findings suggested a potential influence on kidney health in this specific experimental model. Another study explored the in vivo antioxidant effect of aqueous root bark, stem bark, and leaves extracts of Vitex doniana in rats with carbon tetrachloride-induced liver damage, which can also impact overall systemic health, including the kidneys [7].
These studies provide early indications that certain Vitex species might have properties that could influence kidney function under stress conditions in animals. However, they do not offer definitive conclusions about the kidney safety of Vitex agnus-castus in humans or its general use during perimenopause. More specific research on vitex and kidney safety in humans is needed to understand any direct or indirect effects on kidney function.
Considerations for Perimenopausal Women
For women navigating perimenopause and menopause, maintaining optimal liver and kidney health is paramount. While the existing research on vitex and these organs offers some interesting preliminary insights, it is important to interpret these findings cautiously. Most of the evidence suggesting protective effects comes from animal studies involving specific types of Vitex and models of induced organ damage, not from studies on Vitex agnus-castus in healthy human populations.
There is currently limited direct evidence regarding the impact of Vitex agnus-castus on liver and kidney function in healthy women using it for perimenopausal symptoms. While some studies point to potential benefits in specific contexts, these do not equate to a guarantee of safety or benefit for all individuals. The overall liver and kidney safety profile of vitex in healthy human populations requires more dedicated research.
References
- Vitex agnus castus: a systematic review of adverse events. Drug safety, 2005
- Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta medica, 2013
- Standardized extract of Vitex doniana Sweet stalls protein oxidation, lipid peroxidation and DNA fragmention in acetaminophen-induced hepatotoxicity. Journal of ethnopharmacology, 2015
- Hepatoprotective activity of Vitex negundo leaf extract against anti-tubercular drugs induced hepatotoxicity. Fitoterapia, 2008
- Studies on hepatoprotective activity of vitex leucoxylon L. Ancient science of life, 1997
- Effect of oral administration of ethanolic extract of Vitex negundo on thioacetamide-induced nephrotoxicity in rats. BMC complementary and alternative medicine, 2013
- In vivo antioxidant effect of aqueous root bark, stem bark and leaves extracts of Vitex doniana in CCl4 induced liver damage rats. Asian Pacific journal of tropical biomedicine, 2013
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
